DrugBank ID DB01204 Name Mitoxantrone Groups Description An anthracenedione-derived antineoplastic agent. Synonyms Mitoxantrone Mitoxantrone hydrochloride Mitoxantrona 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone Mitoxantronum Brand Names more Indication For the treatment of secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis Categories Analgesics Anthracenes Anthracyclines and Related Substances Anthraquinones Antineoplastic Agents
Antineoplastic and Immunomodulating Agents BCRP/ABCG2 Substrates Cardiotoxic antineoplastic agents Central Nervous System Agents Cytochrome P-450 CYP2E1 Inducers Cytochrome P-450 CYP2E1 Inducers (weak) Cytochrome P-450 CYP2E1 Substrates Cytochrome P-450 CYP2E1 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Cytotoxic Antibiotics and Related Substances Enzyme Inhibitors Immunosuppressive Agents Myelosuppressive Agents Narrow Therapeutic Index Drugs P-glycoprotein inducers P-glycoprotein inhibitors P-glycoprotein substrates P-glycoprotein substrates with a Narrow Therapeutic Index Peripheral Nervous System Agents Quinones Sensory System Agents Topoisomerase II Inhibitors Topoisomerase Inhibitors more ATC-Code L01DB07 CAS number 65271-80-9 
